| Not Yet Recruiting | Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Cont NCT06974968 | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | Phase 2 |
| Not Yet Recruiting | Evaluating a Shared Decision-making Intervention for Families About Firearm Storage NCT07522112 | Seattle Children's Hospital | N/A |
| Not Yet Recruiting | Evaluation of a Sexual Violence and Intimate Partner Violence Primary Prevention Program Implemented in Drinki NCT07434856 | University of California, San Diego | — |
| Recruiting | Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed Wit NCT06818994 | Gustavo Vazquez | Phase 1 |
| Not Yet Recruiting | A First-in-Human SAD and MAD Study in Healthy Participants to Evaluate Oral YR011 Tablet NCT07285967 | Hangzhou Yirui Pharmaceutical Technology Co., Ltd | Phase 1 |
| Recruiting | Safety and Tolerability of IRL757 in Participants With Parkinson's Disease and Apathy NCT07461220 | Integrative Research Laboratories AB | Phase 1 / Phase 2 |
| Not Yet Recruiting | Safety Exploration and Evaluation of Dexmedetomidine Hydrochloride Nasal Spray for Pre-anesthesia Sedation in NCT07298525 | Sichuan Provincial People's Hospital | Phase 4 |
| Completed | Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single S NCT07312643 | RECORDATI GROUP | Phase 1 |
| Recruiting | A Study of GensSci098 in Subjects With Graves' Disease NCT07286656 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | A Study to Learn More About Prevenar 20 Once it is Out in the Korean Market NCT06760208 | Pfizer | — |
| Not Yet Recruiting | Evaluation of the Efficacy and Safety of Megestrol Acetate in Preventing Nausea and Vomiting Induced by Highly NCT07130617 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | An International Survey on the Use of NIV Outside the ICU NCT07157215 | Dr. Ram Manohar Lohia Hospital | — |
| Not Yet Recruiting | Amino Acid Infusion in Kidney Transplant Recipients NCT06929637 | University Hospital, Martin | N/A |
| Recruiting | Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury NCT06976229 | XellSmart Bio-Pharmaceutical (Suzhou) Co., Ltd. | Phase 1 |
| Not Yet Recruiting | OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs NCT06929182 | Central Hospital, Nancy, France | — |
| Active Not Recruiting | Phase 3 Maternal Safety & Immunogenicity Trial of MVA-BN® in DRC NCT06844500 | Jean-Pierre Van geertruyden | Phase 3 |
| Recruiting | A Clinical Study of GenSci134 in Healthy Adults and Adult Growth Hormone Deficiency(AGHD) NCT07016802 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Bilateral Peribulbar Block for Cataract Surgery NCT07000669 | Tanta University | — |
| Recruiting | Phase 3 Infant Safety & Immunogenicity Trial of MVA-BN® in DRC NCT06844487 | Jean-Pierre Van geertruyden | Phase 3 |
| Completed | Purified Exosome Product (PEP) Injected Into the Hypodermis NCT06429033 | Clinical Testing of Beverly Hills | Phase 1 |
| Recruiting | Safety, Tolerability, and Pharmacokinetics of RCS-21 in Healthy Volunteers. NCT06752122 | RNATICS GmbH | Phase 1 |
| Completed | A Phase 1 Study of Y-3 in US Healthy Volunteers. NCT06770491 | Neurodawn Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Long-Term PEA Safety Study NCT06717867 | RDC Clinical Pty Ltd | Phase 2 |
| Recruiting | Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination NCT06733675 | Basilea Pharmaceutica | Phase 1 |
| Completed | Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students NCT07438236 | Cooperativa de Ensino Superior, Politécnico e Universitário | N/A |
| Not Yet Recruiting | HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study NCT06638814 | Treviso Regional Hospital | — |
| Recruiting | Comparison of the Analgesic Effect of Oliceridine Versus Morphine or Sufentanil for Postoperative Analgesia in NCT06990893 | Anqing Municipal Hospital | N/A |
| Completed | Evaluation of Safety and Human Tolerance of Oral Probiotic Streptococcus Salivarius eK12 NCT06380270 | Liaquat University of Medical & Health Sciences | N/A |
| Recruiting | Phase 1/2 Clinical Study of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors NCT06639256 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Enrolling By Invitation | A Phase I/II Clinical Study to Evaluate the Safety and Efficacy of Oral Teslanbaicin in Patients With Radiatio NCT06974123 | The First Affiliated Hospital of Xinxiang Medical College | Phase 1 / Phase 2 |
| Not Yet Recruiting | Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy for Neoadjuvant Treat NCT06542549 | Anhui Provincial Hospital | Phase 3 |
| Not Yet Recruiting | Fluzoparib in Combination With Apatinib Mesylate for Maintenance Therapy in Stage III-IV Ovarian Cancer NCT06539091 | Anhui Provincial Hospital | Phase 3 |
| Recruiting | A Study of GenSci098 in Subjects With Active Thyroid Eye Disease NCT06569758 | Changchun GeneScience Pharmaceutical Co., Ltd. | Phase 1 |
| Completed | Simultaneous mRNA COVID-19 and IIV Vaccination in Pregnancy Study NCT06503900 | Duke University | Phase 4 |
| Enrolling By Invitation | Evaluation of Ascorbate-Meglumine Therapeutic for SRS NCT06433791 | LadeRx LLC | Phase 1 |
| Recruiting | Safety of Elacestrant in ER+/HER2- and ESR1 Mutations MBC NCT06544577 | SciClone Pharmaceuticals | — |
| Completed | Safety and Efficiency of Electrocautery De-Epithelization in Mammoplasty NCT06870695 | Tanta University | — |
| Completed | Safety Profile of a New Berberine Formulation with Improved Bioavailability NCT06732908 | Isura | N/A |
| Completed | Empowering Preschool Children With Personal Safety Skills NCT07454538 | Karabuk University | N/A |
| Suspended | Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus NCT06310811 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Terminated | Trial to Assess Acceptability and Safety of Two Placebo Intravaginal Rings NCT06163274 | University of Pittsburgh | EARLY_Phase 1 |
| Recruiting | Phase 1/2 Study of HYP-2090PTSA in Patients With Advanced Solid Tumors Harboring KRAS Mutation NCT06243354 | Sichuan Huiyu Pharmaceutical Co., Ltd | Phase 1 / Phase 2 |
| Recruiting | Efficacy and Safety of AK104 Combined With Chemotherapy and Cetuximab or Bevacizumab NCT07253896 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Recruiting | Radiotherapy Plus Anlotinib in LA-NSCLC Intolerable to cCRT NCT07037680 | JIANYANG WANG | Phase 2 |
| Completed | Safety and Bioavailability of Micellar Green Tea Extract NCT06971536 | Isura | N/A |
| Unknown | Efficacy and Safety Prediction of Milrinone or Levosimendan as Initial Inotropic Drug Therapy in Patients With NCT06205758 | Yi Han | — |
| Completed | A Study of GC101 TIL in Advanced Melanoma (BZ) NCT06120712 | Shanghai Juncell Therapeutics | Phase 1 / Phase 2 |
| Completed | MATRIX-002: Trial to Assess Acceptability and Safety of Two Placebo Vaginal Films NCT06046053 | Rohan, Lisa, PhD | EARLY_Phase 1 |
| Unknown | Giochiamo 626 - Gaming for Health and Safety in Workplaces NCT06060379 | Universitas Mercatorum | N/A |
| Unknown | Tirelizumab Combined With Chemotherapy in the Treatment of HER-2 Negative Locally Advanced Gastric Cancer NCT06284746 | Lin Chen | Phase 2 |
| Unknown | Study of the Clinical Benefits of Different Formulations of Amphotericin B NCT06123832 | Qianfoshan Hospital | — |
| Unknown | Effect of PPV+ILM Peeling +/- Subretinal Injection of Ringer Lactate in Management of Nontractional Refractory NCT06271473 | Ain Shams University | N/A |
| Recruiting | Curcumin and Retinal Study NCT05774704 | Texas Tech University Health Sciences Center | Phase 1 / Phase 2 |
| Active Not Recruiting | FCN-338 in Combination With Azacitidine or Chemotherapy in Myeloid Neoplasms NCT06858618 | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Phase 2 |
| Completed | Single Ascending Doses of Kratom in Healthy Nondependent Adults With Opioid Experience NCT06072170 | Altasciences Company Inc. | Phase 1 |
| Unknown | Stereotactic Body Radiotherapy Combined With Cadonilimab for Advanced Refractory Malignant Solid Tumors NCT05915481 | Peking University Third Hospital | Phase 1 / Phase 2 |
| Unknown | A Phase II/III Study to Evaluate the Immunogenicity and Safety and Efficacy of SWIM816 Vaccines for SARS-CoV-2 NCT05911087 | Stemirna Therapeutics | Phase 2 / Phase 3 |
| Unknown | Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and NCT05913271 | Yi Han | — |
| Unknown | Human Cord Blood Mononuclear Cells in the Treatment of Refractory Diabetic Foot NCT05999656 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Unknown | Upfront Resection of Locally Advanced NSCLC Followed by Chemoradiotherapy NCT05620199 | The Netherlands Cancer Institute | N/A |
| Completed | Phase 1 Clinical Trial of RHN-001 in Healthy Adult Volunteers NCT05847218 | RH Nanopharmaceuticals | Phase 1 |
| Unknown | Venetoclax Plus IM2 Regimen for Relapsed and Refractory T Lymphoblastic Lymphoma/Leukemia NCT05576532 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Recruiting | Safety and Efficacy of Distal Radial Approach (SAFE-BOX) NCT05776550 | Yonsei University | — |
| Completed | Pharmacokinetics, Safety, and Tolerability of Intramuscular 5-MeO-DMT in Healthy Volunteers NCT05698095 | Usona Institute | Phase 1 |
| Completed | Effect of Diuretics Withdrawal in Chronic Heart Failure With Reduced Ejection Fraction NCT05964738 | Maimónides Biomedical Research Institute of Córdoba | Phase 2 |
| Completed | Combination of Ertugliflozin And Sitagliptin Efficacy, Safety & Tolerability (CEASE Diabetes) Study NCT05556291 | Getz Pharma | — |
| Unknown | Effectiveness of a Communication Device in Home Care Services in Norway: Does Komp Make Older Adults Feel Happ NCT05919355 | Oslo Metropolitan University | N/A |
| Completed | Intensive Care Nurses' Training Package on the Safety Culture of Geriatric Patients NCT05910918 | Alexandria University | N/A |
| Unknown | Phase-I Study to Evaluate the Safety and Immunogenicity of a Prophylactic pDNA Vaccine Candidate Against COVID NCT05171946 | Iman Almansour | Phase 1 |
| Recruiting | PyloPlus Urea Breath Test System Pediatric Safety and Efficacy Study NCT05276557 | ARJ Medical, Inc. | Phase 3 |
| Completed | Relative Bioavailability of Linaprazan for the Test Formulation vs. Reference Formulation NCT05627518 | Cinclus Pharma Holding AB | Phase 1 |
| Unknown | A Phase Ic/IIb Study to Evaluate the Efficacy，Safety and Pharmacokinetics of HST in Patients With CHB NCT06122454 | Xi'an Xintong Pharmaceutical Research Co.,Ltd. | Phase 1 / Phase 2 |
| Unknown | mRNA Booster Vaccine(SW-BIC-213) Compared With Pfizer andSinopharm Against Emerging VOCs NCT05686161 | Stemirna Therapeutics | Phase 3 |
| Completed | Immunogenicity and Safety of Concomitant Administration of Bivalent COVID-19 Vaccines With Influenza Vaccines NCT05970887 | Catholic Kwandong University | Phase 4 |
| Completed | A Phase I Study of GC101 TIL in Advanced Solid Tumors NCT05417750 | Shanghai Juncell Therapeutics | Phase 1 |
| Unknown | New Generation mRNA Booster Vaccine Against Emerging VOCs NCT05580159 | Stemirna Therapeutics | Phase 3 |
| Completed | Safety and Tolerability of a Novel Amino-acid Based Hydration Drink in Healthy Volunteers NCT05592951 | University of Memphis | N/A |
| Unknown | The Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine (SYS6006) as Heterologous Booster in Participants Age NCT05492643 | Zhongnan Hospital | N/A |
| Completed | Study of Single Doses of SBT115301 in Healthy Participants NCT05388981 | Sonoma Biotherapeutics, Inc. | Phase 1 |
| Unknown | Bioequivalence Study of Ezetimibe Tablets Under Fed Conditions in Healthy Subjects NCT05481385 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Completed | Developing a Dyadic Shared Decision Making Tool About Firearm Storage NCT05451355 | Seattle Children's Hospital | N/A |
| Unknown | Remimazolam Improves the Safety in Elderly Patients Undergoing Gastrointestinal Endoscopy NCT05406102 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Unknown | Efficacy and Safety of Memantine and Sodium Oligomannate in Patients With Moderate to Severe Alzheimer's Disea NCT05430867 | First Affiliated Hospital Xi'an Jiaotong University | Phase 4 |
| Unknown | A Phase II Clinical Study of Stereotactic Radiation Therapy in Patients With High-risk Prostate Cancer NCT05430737 | West China Hospital | N/A |
| Completed | Pharmacokinetics and Safety of a New Micellar Glutathione Formulation NCT06345950 | Factors Group of Nutritional Companies Inc. | N/A |
| Completed | Study to Improve Adolescent Bicycling Safety NCT05265689 | Cara J. Hamann | N/A |
| Unknown | Bioequivalence Study of Ezetimibe Tablets Under Fasting Conditions in Healthy Subjects NCT05381870 | The Affiliated Hospital of Qingdao University | Phase 1 |
| Unknown | A Sub-Chronic Evaluation of the Safety of Celastrol in Human Subjects NCT05494112 | Legend Labz, Inc. | N/A |
| Recruiting | Endoscopic Ultrasound-Guided Gastroenterostomy Nationwide: Prospective Registry. NCT05128604 | Hospital Universitari de Bellvitge | — |
| Completed | "Safety in Dementia": An Online Caregiver Intervention NCT05173922 | University of Colorado, Denver | N/A |
| Recruiting | Observational of Adjuvant Treatment of Breast Cancer With Liposomal Doxorubicin Regimen NCT05731258 | Second Affiliated Hospital, School of Medicine, Zhejiang University | — |
| Terminated | Single and Multiple Intravenous Administrations of Estetrol (E4) in Healthy Adult Volunteers NCT05460065 | NEURALIS s.a. | Phase 1 |
| Unknown | PD-L1 Inhibitor Rechallenge After PD-1 Immunotherapy for Patients With Solid Tumor Beyond Lung Cancer NCT05325684 | The Affiliated Hospital of Qingdao University | Phase 1 / Phase 2 |
| Active Not Recruiting | Korea Comirnaty Post-marketing Surveillance NCT05032976 | Pfizer | — |
| Completed | Safety and Acceptability of Q GRFT Nasal Spray for COVID-19 Prophylaxis NCT05180500 | Sharon Hillier | Phase 1 |
| Completed | Clinical Trial on Pharmacokinetics and Tolerability of AP707 NCT05267769 | CannaXan GmbH | Phase 1 |
| Completed | A Clinical Study to Evaluate the Safety, Pharmacokinetic Profile and Efficacy of CU-20401 NCT05195541 | Cutia Therapeutics（Wuxi）Co.,Ltd | Phase 1 / Phase 2 |
| Unknown | a Prospective Registration Study for Patients With Advanced Refractory Solid Tumors NCT05177666 | The University of Hong Kong-Shenzhen Hospital | — |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD7503 in Healthy Participants NCT05143905 | AstraZeneca | Phase 1 |
| Completed | Study Evaluating the Safety and Tolerability of a Probioitc NCT05044949 | BioGaia AB | N/A |
| Completed | Safety of Ascending Single and Multiple Doses of Nebulised SoftOx Inhalation Solution in Healthy Subjects NCT05188638 | SoftOx Solutions AS | Phase 1 |
| Unknown | Combined Immunization of COVID-19 Inactivated Vaccine With QIV and PPV23 NCT05298800 | Centers for Disease Control and Prevention, China | Phase 4 |
| Unknown | Nalbuphine Versus Morphine for Perioperative Tumor Ablation NCT05073744 | Zhongda Hospital | Phase 4 |
| Completed | Efficacy of Ivermectin in COVID-19 NCT05076253 | Bangkok Metropolitan Administration Medical College and Vajira Hospital | Phase 1 / Phase 2 |
| Unknown | Study to Compare PK & Safety of Advixa With Humira in Healthy, Adult Subject Followed by Efficacy & Safety Stu NCT05172817 | Institute for Developing Science and Health Initiatives, Bangladesh | Phase 2 / Phase 3 |
| Unknown | Tenofovir Alafenamide to Prevent Perinatal Transmission of Hepatitis B NCT04850950 | The First Affiliated Hospital of Zhengzhou University | Phase 4 |
| Completed | Midazolam Efficacy/Safety in Pre-Eclamptic C-Section Sedation NCT07021521 | Zhuji People's Hospital of Zhejiang Province | N/A |
| Completed | Safety of Locally Delivered Allogeneic Mesenchymal Stromal Cells NCT04626583 | University of Illinois at Chicago | Phase 1 |
| Completed | Autologous Adipose Derived Stem Cells Transplantation in the Treatment of Keloids. NCT04553159 | Makerere University | Phase 2 |
| Unknown | Clinical Study to Evaluate the Safety and Efficacy of New Probiotic Strains in Health Adults NCT04758845 | Deerland Enzymes | N/A |
| Completed | JOTROL PK, Safety, and Food Effect Assessment NCT04668274 | Jupiter Orphan Therapeutics Inc. | Phase 1 |
| Completed | Bioequivalence Clinical Trial of Recombinant Human Follicle-stimulating Hormone JZB30 NCT06778304 | West China Second University Hospital | Phase 1 |
| Unknown | Almonertinib Combined With Pyrotinib in the Treatment of Advanced NSCLC Patients With HER-2 Amplification/Muta NCT04785729 | Sun Yat-sen University | Phase 2 |
| Completed | Safety, Compliance and Pharmacokinetics of Estetrol Monohydrate/Drospirenone 15/3 mg in Post-menarchal Female NCT04792385 | Estetra | Phase 3 |
| Unknown | Predictive Biomarker for Efficacy and Safety of Combination of Chemotherapy and Tislelizumab in NSCLC NCT05244837 | Hao Long | Phase 2 |
| Completed | Safety, Tolerability and Pharmacokinetics of AM1476 in Healthy Subjects NCT04691115 | AnaMar AB | Phase 1 |
| Completed | Study of the Safety, Tolerability, and PK of MRX-8 Administered Intravenously to HVs in SAD and MAD Cohorts NCT04649541 | MicuRx | Phase 1 |
| Completed | Comparison of Immunogenicity and Safety of DTP-HB-Hib (Bio Farma) With Pentabio® Vaccine Primed With Recombina NCT04071379 | PT Bio Farma | Phase 3 |
| Unknown | Safety and Efficacy of Sodium Bicarbonate Ringer Injection NCT04596956 | Chinese PLA General Hospital | Phase 4 |
| Completed | Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+ NCT04693429 | Laboratorios Sophia S.A de C.V. | Phase 1 |
| Completed | Safety and Pharmacokinetics of Two Vaginal Film Formulations Containing the Integrase Inhibitor MK-2048 NCT04319718 | Hillier, Sharon, PhD | Phase 1 |
| Completed | Randomized Cross-Over Study of Self-Insertion of Two Placebo Vaginal Film Formulations NCT04391036 | Katherine Bunge | N/A |
| Unknown | Efficacy and Safety of Nintedanib in the Treatment of Pulmonary Fibrosis in Patients With Moderate to Severe C NCT04338802 | Huilan Zhang | Phase 2 |
| Completed | Clinical Trial on Pharmacokinetic and Tolerability of AP701 NCT04708795 | CannaXan GmbH | Phase 1 |
| Completed | National Project to Implement Mesenchymal Stem Cell for the Treatment of Perianal Crohn's Fistula (the PRIME S NCT05210309 | Universidad de Zaragoza | — |
| Completed | Clinical Trial ROBERT® - Project Active Training NCT04304976 | Lifescience-Robotics | N/A |
| Unknown | The Impacts of the Different Anesthesia Methods on Patients of Transbronchial Cryobiopsy NCT04099069 | Guangzhou Institute of Respiratory Disease | N/A |
| Completed | Safety of RIV4 Versus IIV4 in Pregnant Women NCT03969641 | Duke University | Phase 4 |
| Completed | A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of PRV-3279 in Healthy NCT03955666 | Provention Bio, Inc. | Phase 1 |
| Completed | Evaluating QTc, PK, Safety of Gemtuzumab Ozogamicin (GO) in Patients With CD33+ R/R AML NCT03727750 | Pfizer | Phase 4 |
| Completed | EMaBS TB Vaccine Study NCT03681860 | University of Oxford | Phase 1 / Phase 2 |
| Unknown | The Diagnostic Yield and Safety of Transbronchial Cryobiopsy in Different Freezing Time in the Diffuse Parench NCT03927235 | Guangzhou Institute of Respiratory Disease | N/A |
| Unknown | Combination Therapy of Umbilical Cord Blood and Erythropoietin for Stroke Paients NCT04013646 | Bundang CHA Hospital | Phase 1 / Phase 2 |
| Terminated | Single and Multiple Dose Escalation Trial of an Intravenous Antibiotic RC-01 NCT03832517 | Recida Therapeutics, Inc. | Phase 1 |
| Unknown | RDD Versus VDD in Newly Diagnosed Patients With Multiple Myeloma NCT03908138 | Shandong Provincial Hospital | Phase 4 |
| Unknown | The Effects Probiotic Has on Gastromicroecology and Combined With Quadruple Regimen for H Pylori Infection NCT03377933 | Yiqi Du | N/A |
| Unknown | Suprachoroidal Injection of Triamcinolone Acetonide for Management of Diabetic Macular Edema NCT04069780 | Azza Mohamed Ahmed Said | N/A |
| Completed | A Trial Investigating the Effect of 4 Weeks Dosing of XEN-D0501 on Blood Glucose Reduction in Patients With Di NCT05353686 | Pila Pharma | Phase 2 |
| Completed | Malaria Vaccine Pilot Evaluation NCT03806465 | Rafiq OKINE | — |
| Completed | Xanamem™ in Healthy Elderly Subjects NCT03830762 | Actinogen Medical | Phase 1 |
| Completed | Analgesia in ÖAMTC Helicopter Emergency Service in Austria NCT03760302 | Medical University Innsbruck | — |
| Completed | Safety, Tolerability and Immune Effects of the Nasal Foralumab in Healthy Human Volunteers NCT06879067 | Tiziana Life Sciences LTD | Phase 1 |
| Completed | Pharmacokinetics of Intravenous, Rectal, Intravesical, Vaginal, and Transdermal Melatonin in Healthy Female Vo NCT03519750 | Dennis Bregner Zetner | Phase 1 |
| Unknown | A Study to Assess the Safety and Pharmacokinetics of Oral Sodium Oligo-mannurarate (GV-971) in Healthy Chinese NCT03715114 | Shanghai Greenvalley Pharmaceutical Co., Ltd. | Phase 1 |
| Recruiting | Human Amniotic-Derived Mesenchymal Stem Cell Therapy for Calciphylaxis NCT04592640 | The First Affiliated Hospital with Nanjing Medical University | EARLY_Phase 1 |
| Completed | Safety, Tolerability, PK and PD of SAD or MAD of APX-115 in Healthy Male Volunteers NCT03694041 | Aptabio Therapeutics, Inc. | Phase 1 |
| Completed | STRENGTH Pilot Project: A Study of a Women-led, Trauma-informed Model of Outreach to Foster Equity NCT06854770 | University of British Columbia | N/A |
| Terminated | TCR Modified T Cells MDG1011 in High Risk Myeloid and Lymphoid Neoplasms NCT03503968 | Medigene AG | Phase 1 / Phase 2 |
| Completed | Renoir: A Randomised, Double-blind, Controlled Trial to Evaluate the Effects of a New Human Milk Fortifier on NCT03315221 | Nutricia Research | Phase 2 / Phase 3 |
| Completed | A Study to Evaluate the Safety and Pharmacokinetics of MEDI0382 in Overweight/Obese Subjects of Japanese or Ch NCT03385369 | MedImmune LLC | Phase 1 |
| Completed | Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy NCT04014426 | Institut du Cancer de Montpellier - Val d'Aurelle | N/A |
| Completed | A Study to Evaluate the Performance and Safety of GP0045 for Correction of Moderate to Severe Nasolabial Folds NCT03300466 | Galderma R&D | N/A |
| Unknown | Standardization of Multi-modal Tumor Ablation Therapy System NCT03223142 | Shanghai Zhongshan Hospital | N/A |
| Completed | A Study to Evaluate the Safety Following Injection of GP0045 Compared to Restylane Lyft Lidocaine NCT03133325 | Galderma R&D | N/A |
| Active Not Recruiting | Prospective G7 Dual Mobility Total Hip PMCF NCT03308929 | Zimmer Biomet | — |
| Terminated | First in Human Single Ascending Dose Study of MOR107 NCT03067363 | Alan Richardson | Phase 1 |
| Withdrawn | Evaluation of COVA™+ CARD in Adult Cardiac Surgery NCT03140098 | Biom'Up France SAS | — |
| Completed | Single Dose Escalation and Multiple Dose Escalation Trial of an Intravenous Formulation of MRX-4 NCT03033329 | MicuRx | Phase 1 |
| Completed | Single Dose and Multiple Dose Escalation Trial of an Oral Formulation of MRX-4 NCT03033342 | MicuRx | Phase 1 |
| Completed | Samsca PMS in ADPKD Patients NCT03406286 | Korea Otsuka Pharmaceutical Co., Ltd. | — |
| Completed | Safety and Tolerability of MEDI9314 as Single Ascending Dose in Healthy Subjects NCT02669667 | MedImmune LLC | Phase 1 |
| Completed | Pentoxifylline PKB171 Gel in Healthy Females Volunteers NCT07017114 | Prokrea BCN, S.L. | Phase 1 |
| Completed | Hodgkin Lymphoma Treatment With Adcetris and Levact in the Old Patient NCT02467946 | Centre Antoine Lacassagne | Phase 1 / Phase 2 |
| Completed | A Single Ascending Dose Study To Assess The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of AZD NCT02512575 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Pharmacokinetics and Safety of Single Doses of Anifrolumab in Healthy Subjects NCT02601625 | AstraZeneca | Phase 1 |
| Withdrawn | A Study to Compare the Pharmacokinetics of Different Formulations of AZD9977 and the Influence of Food in Heal NCT02560363 | AstraZeneca | Phase 1 |
| Unknown | Misodel or Angusta for Induction of Labour? NCT02693587 | Holbaek Sygehus | — |
| Completed | Oral Bio-equivalence Study NCT05145621 | Alembic Pharmaceuticals Ltd. | Phase 1 |
| Unknown | Clinical Trial for the Application of Robotic System in Spinal Surgery NCT03512379 | Beijing Jishuitan Hospital | N/A |
| Completed | A Study to Assess the Safety, Tolerability and Pharmacokinetics of AZD9977 After Single Ascending Doses to Hea NCT02484729 | AstraZeneca | Phase 1 |
| Completed | Individualized Comparative Effectiveness of Models Optimizing Patient Safety and Resident Education. NCT02274818 | University of Pennsylvania | N/A |
| Completed | A Multiple Dosing (14 Days) Study to Assess Efficacy and Safety of Three Dose Levels of AZD7594, Given Once Da NCT02479412 | AstraZeneca | Phase 2 |
| Completed | NAVX-010-Phase I Tolerability and Pharmacokinetic Study in Healthy Male Subjects NCT03655522 | Algenis SpA | Phase 1 |
| Unknown | Nurse Administered Propofol Sedation vs. Midazolam With Fentanyl-sedation for Flexible Bronchoscopy: A Randomi NCT02226328 | Copenhagen University Hospital at Herlev | Phase 4 |
| Completed | Assessment of the Accuracy,Feasibility,Safety of Continuous Glucose Monitoring System NCT03120091 | West China Hospital | — |
| Terminated | Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese P NCT02209506 | Takeda | Phase 1 |
| Completed | Safety Study of Deoxycholic Acid for the Reduction of Localized Subcutaneous Fat in the Submental Area in Subj NCT02123134 | Kythera Biopharmaceuticals | Phase 3 |
| Completed | Single Ascending Dose Study Using DS-1971 to Assess Safety, Tolerability, and Pharmacokinetics in Healthy Part NCT02107885 | Daiichi Sankyo | Phase 1 |
| Terminated | RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP NCT02046590 | Erasme University Hospital | N/A |
| Recruiting | DOvEEgene/WISE Genomics: Diagnosing Ovarian and Endometrial Cancer Early Using Genomics NCT02288676 | McGill University | — |
| Completed | Assessment of Single Doses of Oral Dexanabinol in Healthy Subjects NCT02054754 | e-Therapeutics PLC | Phase 1 |
| Completed | Safety Study of ATX-101 (Deoxycholic Acid) in Subjects With Mild or Extreme Fullness of Submental Fat NCT02035267 | Kythera Biopharmaceuticals | Phase 3 |
| Completed | To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses AZD8848 in Healthy NCT01818869 | AstraZeneca | Phase 1 |
| Completed | A Clinical Trial to Investigate Safety and Tolerability of ASP7962 in Healthy Humans NCT01981928 | Astellas Pharma Europe B.V. | Phase 1 |
| Terminated | NeoMET Study in Neoadjuvant Treatment of Breast Cancer NCT01929811 | Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Completed | A Study to Investigate the Effect of Administration of Ceftazidime-avibactam (CAZ-AVI) and Ceftaroline Fosamil NCT01789528 | Pfizer | Phase 1 |
| Unknown | EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study NCT01902238 | Asan Medical Center | N/A |
| Completed | A Phase II Trial to Assess the Safety and Immunogenicity of DNA Priming Administered by the ID Zetajet® With o NCT01697007 | Muhimbili University of Health and Allied Sciences | Phase 2 |
| Completed | To Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Ascending Doses of Inhaled AZD75 NCT01636024 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subject NCT01815684 | Astellas Pharma Europe B.V. | Phase 1 |
| Completed | Operation of a Mobile Telemedicine System in the EMS NCT01647854 | RWTH Aachen University | N/A |
| Completed | Phase Ib, Dose Escalation Study of Oral LDE225 in Combination With BKM120 in Patients With Advanced Solid Tumo NCT01576666 | Novartis Pharmaceuticals | Phase 1 |
| Completed | Study of Selexipag and Its Metabolite ACT-333679 on Cardiac Repolarization in Healthy Male and Female Subjects NCT02206204 | Actelion | Phase 1 |
| Completed | Study to Assess the Safety and the Phosphate Binding Capacity of Renazorb NCT01560884 | Spectrum Pharmaceuticals, Inc | Phase 1 |
| Completed | Bioequivalence Study Comparing Arimidex Tablet and Anastrozole ODF in Japanese Healthy Male Subjects NCT01568281 | AstraZeneca | Phase 1 |
| Completed | Study to Demonstrate the Safety of a Novel Powder Formulation of Lactobacilli in Adults NCT01568567 | Good Food Practice, Sweden | Phase 1 / Phase 2 |
| Completed | Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of NCT01954589 | Idorsia Pharmaceuticals Ltd. | Phase 1 |
| Completed | A Phase II Clinical Trial for Inactivated Vaccine (Vero Cell) Against EV71 in Chinese Children and Infants NCT01399853 | Jiangsu Province Centers for Disease Control and Prevention | Phase 2 |
| Completed | Assessment of Safety, Tolerability and Blood Concentrations of Single Doses of AZD3839 in Healthy Volunteers NCT01348737 | AstraZeneca | Phase 1 |
| Completed | Long-Term Safety of Azilsartan Medoxomil and Chlorthalidone Compared to Olmesartan Medoxomil and Hydrochloroth NCT01309828 | Takeda | Phase 3 |
| Unknown | The Parietal Peritoneum as a Substitute Graft for Venous Reconstruction in HPB Surgery NCT02121886 | Beaujon Hospital | N/A |
| Completed | Study Evaluating a 13-valent Pneumococcal Conjugate Vaccine in Preterm Compared to Term Infants. NCT01193335 | Pfizer | Phase 4 |
| Completed | A First In Human Study In Healthy People To Evaluate Safety, Toleration And Time Course Of Plasma Concentratio NCT01415102 | Pfizer | Phase 1 |
| Completed | Single Centre, Double-blind, Single and Multiple Ascending Inhaled Doses of AZD9819 in Healthy Subjects NCT01166698 | AstraZeneca | Phase 1 |
| Completed | Study Evaluating Antibody Response Of 13-Valent Pneumococcal Conjugate Vaccine (13vPnC) 24 Months After Toddle NCT01026038 | Pfizer | Phase 3 |
| Withdrawn | Phase I, Single Centre, Study to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD3043 NCT01086813 | AstraZeneca | Phase 1 |
| Completed | A Study In Healthy People Of Multiple Doses Of UK-396,082 Given By Mouth, To Investigate The Safety, Toleratio NCT01091532 | Pfizer | Phase 1 |
| Completed | Safety and Pharmacokinetics of SNX-001 in Healthy Aged Volunteers NCT01269476 | SeneXta Therapeutics SA | Phase 1 |
| Completed | AZD2624 Multiple Ascending Dose Study in Japan NCT00696865 | AstraZeneca | Phase 1 |
| Completed | A Study to Assess the Pharmacokinetics, Safety and Tolerability of CT327 in Healthy Male Volunteers NCT01243502 | Creabilis SA | Phase 1 |
| Completed | FDA Phase IV - Commitment - Retinal Function Study NCT00461565 | Bayer | Phase 4 |
| Completed | LabAlert: Enhancing Medication Safety Through Electronic Interventions to Improve Laboratory Monitoring NCT00256386 | Kaiser Permanente | N/A |